by Caden Carter | Mar 29, 2018 | Blog, fda-otc-drugs
Cosmetic companies often find they are making drug claims on their product mainly due to two parts of the definition of a drug. First, a drug claim is any claim that the product has an intended use in the “diagnosis, cure, mitigation, treatment, or prevention of...
by Cory Carter | Mar 27, 2018 | Blog, FDA Audits
Over the last 50 years, companies have relied heavily on lawyers from big firms to review labels, advise on advertising compliance, interface with the FDA on their behalf, etc. Today, there are FDA regulatory consulting firms, like our firm, who market services that...
by Cory Carter | Mar 14, 2018 | Blog
We meet dietary supplement companies regularly who are shocked when the FDA shows up to inspect their company for cGMP compliance when the company doesn’t produce any product. Is the FDA off their rocker? In short – no. All companies who market dietary...
